These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 12030956)

  • 1. Meta-analysis: the efficacy of intravenous H2-receptor antagonists in bleeding peptic ulcer.
    Levine JE; Leontiadis GI; Sharma VK; Howden CW
    Aliment Pharmacol Ther; 2002 Jun; 16(6):1137-42. PubMed ID: 12030956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proton pump inhibitors versus H2-antagonists: a meta-analysis of their efficacy in treating bleeding peptic ulcer.
    Gisbert JP; González L; Calvet X; Roqué M; Gabriel R; Pajares JM
    Aliment Pharmacol Ther; 2001 Jul; 15(7):917-26. PubMed ID: 11421865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of bleeding peptic ulcer: current status of intravenous proton pump inhibitors.
    McCarthy DM
    Best Pract Res Clin Gastroenterol; 2004; 18 Suppl():7-12. PubMed ID: 15588788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Economic and health aspects of peptic ulcer disease and H2-receptor antagonists.
    Jensen DM
    Am J Med; 1986 Oct; 81(4B):42-8. PubMed ID: 2877574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Intravenous gastric acid inhibition for stress ulcers and bleeding peptic ulcers].
    Geus WP; Lamers CB
    Ned Tijdschr Geneeskd; 1999 Dec; 143(50):2514-8. PubMed ID: 10627753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acid suppression in peptic ulcer haemorrhage: a 'meta-analysis'.
    Selby NM; Kubba AK; Hawkey CJ
    Aliment Pharmacol Ther; 2000 Sep; 14(9):1119-26. PubMed ID: 10971227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proton pump inhibitor treatment for acute peptic ulcer bleeding.
    Leontiadis GI; Sharma VK; Howden CW
    Cochrane Database Syst Rev; 2006 Jan; (1):CD002094. PubMed ID: 16437441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proton pump inhibitor treatment for acute peptic ulcer bleeding.
    Leontiadis GI; McIntyre L; Sharma VK; Howden CW
    Cochrane Database Syst Rev; 2004; (3):CD002094. PubMed ID: 15266462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of peptic ulcer with histamine H2 receptor antagonists].
    Domschke W; Domschke S; Demling L
    Fortschr Med; 1977 Aug; 95(31):1899-902. PubMed ID: 19347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical benefits of intravenously administered famotidine in the treatment of upper gastrointestinal hemorrhage caused by peptic ulcer and stress ulcer disease.
    Aoki T
    Scand J Gastroenterol Suppl; 1987; 134():41-5. PubMed ID: 2889257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are there indications for intravenous acid-inhibition in the prevention and treatment of upper GI bleeding?
    Geus WP
    Scand J Gastroenterol Suppl; 2000; (232):10-20. PubMed ID: 11232484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of upper gastro-intestinal bleeding with the H2-receptor antagonist famotidine.
    Aoki T
    J Int Med Res; 1989; 17 Suppl 1():32A-40A. PubMed ID: 2566542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proton pump inhibitor therapy for peptic ulcer bleeding: Cochrane collaboration meta-analysis of randomized controlled trials.
    Leontiadis GI; Sharma VK; Howden CW
    Mayo Clin Proc; 2007 Mar; 82(3):286-96. PubMed ID: 17352364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of acid-suppression therapy for treatment of non-variceal upper gastrointestinal bleeding.
    Olsen KM
    Am J Health Syst Pharm; 2005 May; 62(10 Suppl 2):S18-23. PubMed ID: 15905596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of feeding on gastric acid suppression in Helicobacter pylori-positive patients treated with a proton pump inhibitor or an H2-receptor antagonist after bleeding from a gastric ulcer.
    Ozawa T; Yoshikawa N; Tomita T; Akita Y; Mitamura K
    J Gastroenterol; 2003; 38(9):844-8. PubMed ID: 14564629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The efficacy and safety of proton pump inhibitors vs histamine-2 receptor antagonists for stress ulcer bleeding prophylaxis among critical care patients: a meta-analysis.
    Lin PC; Chang CH; Hsu PI; Tseng PL; Huang YB
    Crit Care Med; 2010 Apr; 38(4):1197-205. PubMed ID: 20173630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Do proton pump inhibitors after endoscopic control of acute ulcer hemorrhage have an advantage over H2 receptor antagonists?].
    Prassler R; Hendrich H; Barnert J; Richter G; Fleischmann R; Wienbeck M
    Z Gastroenterol; 1995 Aug; 33(8):431-4. PubMed ID: 7483734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histamine H2-receptor antagonists in peptic ulcer disease. Evidence for a prophylactic use.
    Nash J; Lambert L; Deakin M
    Drugs; 1994 Jun; 47(6):862-71. PubMed ID: 7521828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of histamine H2 receptor antagonists in nonoperative management of gastroduodenal ulcer haemorrhage.
    Haglund U
    Scand J Gastroenterol Suppl; 1987; 137():39-42. PubMed ID: 2892262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Proton pump inhibitors in the treatment of peptic ulcers resistant to H2-receptor antagonists].
    Asaka M; Kato M; Sato Y; Miyazaki T
    Nihon Rinsho; 1992 Jan; 50(1):104-10. PubMed ID: 1347322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.